Answers are grounded in this paper and cite their sources.
Sepsis is a potentially life-threatening condition and is one of the leading causes of mortality and morbidity worldwide, as it occurs in response to infection with a dysregulated host response. Thus, it is essential to discover accurate biomarkers that facilitate timely identification. We attempted to assess the diagnostic value of C-reactive protein (CRP), interleukin-6 (IL-6) and procalcitonin (PCT) for predicting blood culture positivity in patients with suspected sepsis. Of 196 patients, 84 (43%) had positive blood cultures. Patients with blood culture-positive patients had significantly higher mean values of PCT (29.1 ± 11.9 ng/mL), IL-6 (836.8 ± 265.6 pg/mL), and CRP (225.5 ± 44.7 mg/L) compared with culture-negative patients (p < 0.001). The most frequently identified isolate was methicillin-resistant Staphylococcus aureus (MRSA) (42%), followed by Klebsiella pneumoniae (26%) and Escherichia coli (21%). ROC (Receiver operating characteristic) investigation showed that PCT with significant diagnostic efficacy (AUC: 0.893; 95% CI, [0.84--0.93]) with a sensitivity of 79.8% and specificity of 83.9% at a cut-off value of ≥ 20 ng/mL used in severe sepsis method for diagnosis. For PCT, CRP and IL-6 had the highest specificity (99.1%) with cut-off value at 876 pg/mL; while CRP showed a higher sensitivity (91.7%) than other two markers with a cut-off value at 167 mg/L. Spearman's correlation analysis of each marker demonstrated that PCT was most positively correlated with blood culture positivity (ρ = 0.675), followed by interleukin-6 (ρ = 0.633) and C-reactive protein (ρ = 0.600). The results suggest that in patients with sepsis, procalcitonin has better diagnostic accuracy than interleukin-6 and C-reactive protein for predicting blood culture positivity. In bloodstream infection, significant associations were found for each biomarker; but balance between sensitivity/specificity was best for PCT. In conclusion, inclusion of PCT, IL-6 and CRP into routine clinical assessment may help in the early diagnosis of sepsis and improve antimicrobial stewardship regarding the future management of this patient population.
No takes yet. Share an insight, caveat, or question.
Sureshkumar et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: